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A derivative of the pEX3 expression vector was constructed that codes for the first 407 amino acids of the 1051 amino 
acids of the pEX3 fusion protein. The amount of truncated fusion protein (40 mg/g cells), obtained by expression in 
E. coli, was similar to that produced by the original pEX3 vector. The truncated fusion protein was purified more easily 
from E. co/i contaminants than the original fusion protein by washing with 2 M urea and 0.5% Triton X-100. 
pEX fusion protein; Truncated form; Protein purification 
1. INTRODUCTION 
Recombinant ,&galactosidase fusion proteins, 
produced in E. co/i, are widely used for different 
purposes. They are used as immunogen to elicit an- 
tibodies to the foreign part of the fusion protein 
[l-5], or as an agent to stimulate T-cell prolifera- 
tion [6]. Furthermore, they are used in probing the 
topology of a foreign protein [7-lo], or as a tag to 
detect minor proteins in E. coli [l 11. 
In general, the fusion proteins contain nearly the 
complete ,&-galactosidase sequence. Alternatively, 
truncated forms of ,&-galactosidase have been used 
to produce human proinsulin [12]. An example of 
the first class of fusion proteins is the pEX fusion 
protein [ 131. The pEX vector codes for a protein of 
1051 amino acids which by itself is a fusion of 3 
protein fragments, viz. cro, lac1 and 1acZ. The 
pEX fusion protein forms insoluble aggregates in 
the cells and is expressed to about 25% of total cell 
protein [ 131. DNA fragments up to 400 bp can be 
cloned into the pEX plasmids at the C-terminus of 
the cro-IacI-IacZ sequence without substantial loss 
Correspondence address: C.H.M. Kocken, Laboratorium voor 
Medische Microbiologic, Oostersingel 59, 9713 EZ Groningen, 
The Netherlands 
of efficiency of expression of the fusion protein 
[131. 
Partial purification of the fusion protein can be 
achieved by the collection of the insoluble material 
after cell lysis. Further purification of this fusion 
protein in sufficient quantities is hampered by its 
insolubility. Chromatographic procedures can be 
applied after solubilization of the fusion protein by 
boiling in SDS to disrupt aggregates of E. co/i pro- 
teins and the fusion protein. Contaminating pro- 
teins from E. cofi may interfere when fusion 
proteins are used in immunological assays and 
have e.g. a non-specific effect on T-cell prolifera- 
tions [6]. Therefore, it would be advantageous to 
produce a fusion protein that associates to a lesser 
extent with E. coli contaminants and therefore 
would be much easier to purify. 
In the present study we report the construction 
of a pEX derivative that codes for a truncated fu- 
sion protein of 407 amino acids and its purification 
is compared with that of the original pEX fusion 
protein. 
2. MATERIALS AND METHODS 
2.1. Construction of pEX3407 
Recombinant DNA techniques were performed according to 
Maniatis et al. [14]. Expression plasmid pEX3, kindly provided 
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by Dr K.K. Stanley [13], was digested with EcoRV and SmaI 
and the large fragment was isolated by gel electrophoresis. This 
fragment was self-ligated and transformed into E. coli pop 
2136. Ampicillin-resistant colonies were screened for expression 
of a 50 kDa fusion protein. Overnight cultures, grown at 3O”C, 
were induced at 42°C for 90 min, cells were harvested and ali- 
quots were subjected to SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) on a 10% gel according to Laemmli [15]. The 
resulting clone was designated as pEX3407. 
2.2. Purification of fusion proteins 
100 ml cultures of pEX3 and pEX3407 were grown at 30°C 
to 4600 = 0.3 and then shifted to 42°C for 3 h to induce produc- 
tion of the fusion protein. Cells were harvested and lysed by ad- 
dition of lysozyme (0.8 g/g cells) and subsequently deoxy- 
cholate (4 mg/g cells) as described by Marston [ 161. DNA was 
broken by sonication and the cell lysate was centrifuged at 
12000 X g for 15 min at 4°C. The pellet containing the inclu- 
sion bodies was resuspended in 9 vols (v/w) 2 M urea in lysis 
buffer (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 100 mM NaCl) 
and incubated for 5 min at room temperature. The suspension 
was centrifuged at 12000 x g for 5 min at 4°C and the pellet 
was resuspended in 9 vols of lysis buffer, containing 0.5% (v/v) 
Triton X-100 and 10 mM EDTA. After incubation for 5 min at 
room temperature, the suspension was centrifuged as described 
above and the pellet was washed twice with 9 vols of water and 
subsequently lyophilized. Samples were analyzed by SDS- 
PAGE. 
3. RESULTS AND DISCUSSION 
3.1. Construction ofpEX3407 
In fig.1 the construction of pEX3407 is shown. 
The pEX3 vector was digested with EcoRV and 
SmaI and the large fragment was self-ligated. The 
resulting plasmid, designated as pEX3407, codes 
for a truncated form of the cro-lacI-1acZ fusion 
protein of pEX3. The coding region terminates at 
amino acid 407 and is followed by the remainder of 
the linker region of pEX3 in the same reading 
frame as in pEX3. The SmaI site in the linker 
region was deleted by the cloning procedure. The 
truncated pEX3407 fusion protein is expressed at 
about the same high levels as the pEX3 fusion pro- 
tein, and the recovery of both fusion proteins was 
similar, approx. 4 mg fusion protein per 0.1 g cells 
(wet wt). The pEX3407 fusion protein has a 
relative molecular mass of 50 kDa, as compared to 
the original pEX3 fusion protein with a molecular 
mass of 116 kDa. 
3.2. Purification of fusion proteins 
Cells expressing pEX3 and pEX3407 fusion pro- 
teins were lysed with lysozyme and deoxycholate. 
The pEX3 fusion protein and the truncated 
EcoRV 
cro-lacI-1acZ 
fusion protein 
SmaI 
1) cut with EcoRV 
2) cut with SmaI 
3) isolate and ligate 
large fragment 
fusion protein 
PitI 
Fig.1. Construction of pEX3407. pEX3 was digested with 
EcoRV and SmaI and the large fragment was self-ligated to give 
pEX3407. The coding region of the cro-la&IacZ fusion protein 
terminates at amino acid 407. The remaining unique restriction 
sites in the cloning linker are shown. The arrow indicates the 
start and direction of transcription. 
pEX3407 fusion protein exist as insoluble inclusion 
bodies in the bacterial cells. After centrifugation of 
the cell lysate, both fusion proteins are present in 
the pellet and not in the supernatant fraction. This 
is illustrated in fig.2, in which lanes 3 and 6 (pEX3 
fusion protein and pEX3407 fusion protein, 
respectively) show the analysis of proteins present 
in the pellets and lanes 2 and 5 (pEX3 fusion pro- 
tein and pEX3407 fusion protein, respectively) the 
composition of the supernatants. The pellet ob- 
tained after centrifugation of the lysate for cells ex- 
pressing the pEX3407 fusion protein is less 
contaminated with E. co/i proteins than the pellet 
containing the pEX3 fusion protein. An additional 
amount of contaminating proteins was removed by 
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12345678 KD The truncated pEX3 derivative has been suc- 
cessfully used to clone large gene fragments of 
glycoprotein D of herpes simplex virus type 1 
(HSV-1 gD, up to 972 bp) without loss of efficien- 
cy of expression. These relatively large recombi- 
nant gD-fusion proteins were isolated by the 
procedure described here for the pEX3407 fusion 
protein giving similar results and were used for im- 
munization of rabbits (Kocken, C.H.M., un- 
published). 
94 
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Fig.2. Purification steps of fusion proteins of pEX3 and 
pEX3407 cells analyzed by SDS-PAGE. Proteins were 
subjected to SDS-PAGE on a 10% gel under reducing 
conditions. Proteins were stained with Coomassie brilliant blue 
R-250. Molecular mass markers (lanes 1 and 8). Supernatants 
obtained after centrifugation of the lysate of pEX3 (lane 2) and 
pEX3407 (lane 5) cells. Pellets obtained after centrifugation of 
the lysate of pEX3 (lane 3) and pEX3407 (lane 6) cells. Pellets 
after washing of pEX3 (lane 4) and pEX3407 (lane 7) fusion 
proteins, with 2 M urea and 0.5% Triton X-100. 
washing with 2 M urea and 0.5% Triton X-100, 
resulting in approx. 95% pure pEX3407 fusion 
protein (fig.2, lane 7). In contrast to this, the 
original pEX3 fusion protein is still contaminated 
with substantial amounts of E. coli proteins (fig.2, 
lane 4). The use of truncated ,8-galactosidase fu- 
sion proteins of 590 and 450 amino acids [12] did 
not result in more purified preparations after 
precipitation of the fusion protein from a 7 M 
guanidine-HCl cell extract, as compared to the 
original ,&galactosidase fusion protein of 1007 
amino acids. This difference is probably due to the 
fact that the truncated cro-IacI-1acZ fusion protein 
described here is basically a protein other than the 
truncated ,B-galactosidase described by Guo et al. 
u21. 
The truncated pEX derivative may be useful for 
expression of other proteins, particularly for the 
production of specific antibodies and in those 
cases where impure preparations would interfere 
with immunological assays. 
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